Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCG-257081 (MRTF/SRF-IN-1) is an inhibitor of cardiac myosin-related transcription factor and serum response factor (MRTF/SRF) that acts by inhibiting the Rho/MRTF/SRF pathway.CCG-257081 has shown efficacy in preventing bleomycin-induced fibrosis in several mouse models. CCG-257081 can be used in cancer prevention and fibrosis research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 129.00 | |
5 mg | In stock | $ 313.00 | |
10 mg | In stock | $ 466.00 | |
25 mg | In stock | $ 766.00 | |
50 mg | In stock | $ 1,070.00 | |
100 mg | In stock | $ 1,450.00 | |
500 mg | In stock | $ 2,880.00 |
Description | CCG-257081 (MRTF/SRF-IN-1) is an inhibitor of cardiac myosin-related transcription factor and serum response factor (MRTF/SRF) that acts by inhibiting the Rho/MRTF/SRF pathway.CCG-257081 has shown efficacy in preventing bleomycin-induced fibrosis in several mouse models. CCG-257081 can be used in cancer prevention and fibrosis research. |
Synonyms | MRTF/SRF-IN-1, CCG257081, CCG 257081 |
Molecular Weight | 473.87 |
Formula | C24H19ClF3N3O2 |
CAS No. | 1922098-90-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCG-257081 1922098-90-5 Cell Cycle/Checkpoint GPCR/G Protein MAPK Rho Ras MRTF/SRF-IN-1 CCG257081 CCG 257081 inhibitor inhibit